Severe Hyponatremia with Normokalemia in Pembrolizumab-Lenvatinib Combination Therapy for Metastatic Renal Cell Carcinoma: A Case of Suspected Secondary Adrenal Insufficiency and Clinical Differentials. OAIJMR. 2025;6(1):35-50. doi:10.37275/oaijmr.v6i1.826